Searchable abstracts of presentations at key conferences in endocrinology

ea0008p5 | Bone | SFE2004

The effects of Simvastatin on the human osteoblast-like cell, SaOS-2

Abdulkhaliq A , Mancini L , Girgis SI

Background: Statins are widely prescribed cholesterol-lowering drugs. They inhibit cholesterol synthesis through inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase. They have also been recently identified as bone stimulatory agents (Mundy et al., 1999). They have been found to increase the expression of BMP-2 that triggers a cascade of events leading to increased bone formation. However, the exact mechanism for the stimulatory action of statins is not fully elucidat...

ea0090p418 | Pituitary and Neuroendocrinology | ECE2023

Search for new biomarkers of adult growth hormone deficiency metabolic syndrome: a comprehensive overview of a four peptides analysis

Mancini Antonio , Vergani Edoardo , Bruno Carmine , Oliva Alessandro , Curro Diego

Adult growth hormone deficiency (aGHD) is characterized by an altered metabolic profile and increased cardiovascular risk. Neudesin is a newly discovered protein mainly secreted from adipose tissue and brain, under evaluation for its possible activity as negative regulator of energy expenditure. Liver expressed antimicrobial peptide (LEAP)-2 is a competitive antagonist of ghrelin on its receptor. Spexin is a polypeptide related to the galanin-kisspeptin family, secreted along ...

ea0090ep585 | Endocrine-related Cancer | ECE2023

Phenotypic presentation of MEN1 (NM_130799.2):c.758delC (p.Ser253CysfsTer28) rs1592648765 pathogenic mutation of MEN-1 gene: a case report

Vergani Edoardo , Concolino Paola , Traini Emanuela , Macis Giuseppe , Mancini Antonio

Multiple endocrine neoplasia (MEN) 1 is a rare hereditary autosomal dominant tumor syndrome characterized by two or more endocrine tumors. Non-endocrine neoplasms have been described as well. MEN1 is caused by inactivating mutations of the onco-suppressor gene MEN-1 (chromosome 11q13) which encodes the protein menin. Currently, 897 public variants of MEN-1 gene are reported. We present the case of a recently discovered pathogenic mutations of MEN-1 gene. A 32-year-old Italian ...

ea0015p330 | Steroids | SFEBES2008

Salivary cortisol: a possible regulator of salivary annexin 1

Renshaw Derek , Mancini Lucia , Flower Rod , Perretti Mauro

Several hormones, including cortisol, have a circadian rhythm in plasma and saliva. Salivary cortisol is now extensively used for screening and following patients with various conditions where the regulation of hypothalamo–pituitary–adrenal axis is abnormal, for example in major depression where salivary cortisol levels show a disruption or loss of circadian rhythm. Annexin 1 is a glucocorticoid-induced protein, which is responsible for mediating several anti-inflamm...

ea0075p08 | Pituitary and neuroendocrinology | EYES2021

Indexes of chronic low-grade inflammation in different models of insulin-resistance: Evaluation of lipocalin-2 in metabolic sindrome, partial and total growth hormone deficiency

Bruno Carmine , Vergani Edoardo , Curro Diego , Pontecorvi Alfredo , Mancini Antonio

Lipocalin-2 (LCN2) is a glycoprotein synthetized by various cell types, including neutrophils, that acts as siderophores scavenger and play an important role in different chronic inflammatory processes. Metabolic Syndrome (MetS) and Adult Growth Hormone Deficiency (AGHD), both partial and total, are characterized by inflammatory features. The objectives of our cross-sectional study were: 1) to compare LCN2 levels in these clinical pictures; 2) to evaluate the relations between...

ea0075p10 | Pituitary and neuroendocrinology | EYES2021

Hormonal adjustment to metabolic derangement in adult Growth Hormone Deficiency: evaluation of Ghrelin and LEAP-2 serum level

Vergani Edoardo , Bruno Carmine , Curro Diego , Pontecorvi Alfredo , Mancini Antonio

Background: Ghrelin and its endogenous antagonist liver-expressed antimicrobial peptide-2 (LEAP-2) are involved in GH secretion, both acting on GSH-r1α, and regulation of glucose and lipids metabolism. Metabolic impairments are often accompanied by an upregulation of LEAP-2 expression, with a usual concomitant reduction in ghrelin secretion. Adult growth hormone deficiency (aGHD), characterized by weight gain, increased fat mass and insulin resistance, represent a conditi...

ea0081ep677 | Pituitary and Neuroendocrinology | ECE2022

Role of new peptide biomarkers in metabolic profiling of adult growth hormone deficiency patients: preliminary data on neudesin and its relationship with LEAP-2

Vergani Edoardo , Bruno Carmine , Gavotti Cesare , Oliva Alessandro , Curro Diego , Mancini Antonio

Patients affected by adult growth hormone deficiency (aGHD) show worse metabolic profile, with insulin-resistance, increased total cholesterol, LDL, triglycerides, reduced HDL, and higher risk of developing type 2 diabetes mellitus and cardiovascular complications. Adult GHD and metabolic syndrome (MetS) are closely related to each other, since they share the previous depicted clinical features, while obese MetS patients display lower IGF-1 levels due to a functional reduction...

ea0090p726 | Reproductive and Developmental Endocrinology | ECE2023

The impact of pharmacological treatments on oxidative stress, inflammatory parameters and semen characteristics

Zamponi Virginia , Mazzilli Rossella , Olana Soraya , Russo Flaminia , Mancini Camilla , Faggiano Antongiulio , Salerno Gerardo

Introduction: Although the pathogenic mechanism is not completely understood, pharmacological treatments could negatively affect seminal parameters. The analysis of inflammatory (i.e. cytokines) and oxidative stress parameters represent a new tools to investigate the causes of idiopathic male infertility. The aim of this study was to evaluate the impact of medications on oxidative stress, inflammatory parameters and semen characteristics in male with idiopathic infertility.</p...

ea0041ep684 | Female Reproduction | ECE2016

Usefulness of dynamic Tsh evaluation for diagnosis of subclinical hypothyroidism in luteal deficiency

Mancini Antonio , Giacchi Elena , Saporosi Aurora , Olivieri Giulio , Di Segni Chantal , Marana Riccardo , Pontecorvi Alfredo

Introduction: It is known that thyroid disorders can influence menstrual cycle, but subclinical hypothyroidism (SH), as cause of ovulation disorders and luteal deficiency (LD) in particular,is underestimated. Monitoring women’s cycles, according to the Billings Ovulation Method (BOM), can allow a precise timing for hormonal evaluation and diagnose LD. Usually, a basal TSH value of 2.5 mg/ml is considered as cut-off for a good luteal function, but alone cannot identify all...

ea0038p200 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2015

AMPK activators modulate pro-inflammatory responses in human adipocytes

White Anna , Mancini Sarah , Nguyen Dinh Cat Aurelie , Montezano Augusto , Salt Ian , Touyz Rhian

Adipose tissue inflammation may be an important mechanism in the development of systemic insulin resistance, such that modulation of this system may be a therapeutic target for type 2 diabetes and obesity-related disorders. AMPK has anti-inflammatory properties, yet the anti-inflammatory actions of AMPK in adipocytes remain poorly characterised. We questioned whether AMPK activation influences pro-inflammatory responses in cultured adipocytes in basal and stimulated conditions...